Hansoh Pharmaceutical Group Company Limited(HK:3692)
HK$33.90-0.52 (-1.51%)
HK:3692
Hansoh Pharmaceutical Group Company Limited financials statements
HK$33.90
At close:-0.52 (-1.51%)
Want to see HK:3692 full AI Analyst Report?
Hansoh Pharmaceutical Group Company Limited (3692) Income Statement
8 Followers
Hansoh Pharmaceutical Group Company Limited Income Statement
Last quarter (Q2 2026), Hansoh Pharmaceutical Group Company Limited's total revenue was ¥8.30B, an increase of 27.65% from the same quarter last year. In Q2, Hansoh Pharmaceutical Group Company Limited's net income was ¥4.26B. See Hansoh Pharmaceutical Group Company Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 15.03B | ¥ 12.26B | ¥ 10.10B | ¥ 9.38B | ¥ 9.94B | |
| ¥ 13.51B | ¥ 11.16B | ¥ 9.07B | ¥ 8.51B | ¥ 9.06B | |
| ¥ 8.09B | ¥ 7.12B | ¥ 6.23B | ¥ 5.84B | ¥ 6.17B | |
| Depreciation and Amortization | ¥ 393.02M | ¥ 401.35M | ¥ 366.38M | ¥ 335.77M | ¥ 278.47M |
| ¥ 5.79B | ¥ 4.30B | ¥ 4.20B | ¥ 2.94B | ¥ 3.08B | |
| ¥ 5.42B | ¥ 4.03B | ¥ 2.84B | ¥ 2.67B | ¥ 2.90B | |
| ¥ 1.13B | ¥ 1.05B | ¥ 926.83M | ¥ 277.21M | ¥ 403.58M | |
| ¥ 6.55B | ¥ 5.09B | ¥ 3.77B | ¥ 2.95B | ¥ 3.30B | |
| ¥ 5.56B | ¥ 4.37B | ¥ 3.28B | ¥ 2.58B | ¥ 2.71B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.93 | ¥ 0.74 | ¥ 0.52 | ¥ 0.44 | ¥ 0.46 |
| Diluted EPS | ¥ 0.93 | ¥ 0.73 | ¥ 0.52 | ¥ 0.44 | ¥ 0.44 |
| Weighted Average Shares Outstanding | 5.98B | 5.93B | 6.02B | 5.92B | 5.92B |
| Weighted Average Shares Outstanding (Diluted) | 5.98B | 5.95B | 6.02B | 5.93B | 6.00B |
Currency in CNY

